We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Demonstrates Whole Blood Critical and POC Testing Solutions at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021

Nova Biomedical (Waltham, MA, USA) demonstrated its whole blood critical and POC testing solutions at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo held at the Georgia World Congress Center in Atlanta, September 26-30.

The event provided an unparalleled opportunity to connect with global leaders in laboratory medicine, and to discover cutting edge technology & vital research in the field.

Nova is a world leader in whole blood critical and POC testing, offering hospital meters (including StatStrip Glucose, the only FDA-cleared meter for critically ill testing) and Stat Profile Prime critical care blood gas analyzers. At AACC 2021, Nova demonstrated its Stat Profile Prime Plus - a comprehensive, whole blood critical care analyzer that offers blood gases, electrolytes, metabolites, hematology, and co-oximetry, in a simple, compact device. Prime Plus combines maintenance-free, replaceable cartridge technology for sensors and reagents with patented, maintenance-free, and non-lysing whole blood co-oximetry technology. The analyzer uses a small 135µL sample, produces a complete 22-test panel in about one minute, and offers automated quality control with real-time, supplement quality monitoring of each sample analysis, calibration, and QC analysis. Prime Plus is the only critical care analyzer that includes BUN, creatinine, ionized magnesium, estimated plasma volume, and MCHC in its test menu. The complete test menu includes pH, PCO2, PO2, Na, K, Cl, iCa, iMg, Glucose, Lactate, BUN/Urea, Creatinine, Hct, Hb, estimated Plasma Volume, MCHC, SO2%, and CO-Oximetry.

At AACC 2021, Nova also displayed the StatStrip Glucose Hospital Meter, which is the only glucose meter cleared by the FDA for use with critically ill patients and CLIA-waived for use with ALL patients and ALL sample types. StatStrip Glucose has no known interferences and brings lab-like accuracy to bedside glucose testing - accuracy validated in an FDA submission study of 1,698 critically ill patients with 257 different and specific medical conditions, and over 8,000 medications, as well as over 200 published studies worldwide. StatStrip Glucose measures glucose and corrects for hematocrit, maltose, and other interferences that can cause erroneous results on other meters.

Related Links:
Nova Biomedical 

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








ADLM

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.